State AR
Clinical Trials in Arkansas
Recruiting clinical trials with at least one study location in Arkansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arkansas
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults ...
Condition
Dravet Syndrome
Enrollment
160 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT06784466 N/A
Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patie...
Condition
Atrial Fibrillation (AF)
Enrollment
360 pts
Location
United States, Belgium, Croatia
Sponsor
Arga Medtech SA
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT06634719 N/A
Recruiting
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Condition
Heavy Menstrual Bleeding
Enrollment
7 pts
Location
United States
Sponsor
Rejoni Inc.
NCT07346300 N/A
Recruiting
We-Move With Windy: Gross Motor Development for Early Childhood
Condition
Physical Activities
Enrollment
266 pts
Location
United States
Sponsor
Arkansas Children's Hospital R
NCT07470853 Phase 1
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With A...
Condition
PROC
Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06095960 N/A
Recruiting
Telehealth Multi-Component Optional Model (MOM) Study
Condition
Maternal Health
Enrollment
1,500 pts
Location
United States
Sponsor
University of Arkansas
NCT06070350 Phase 3
Recruiting
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage...
Condition
Hemorrhagic Shock
Enrollment
1,000 pts
Location
United States
Sponsor
Philip Spinella
NCT07308847 N/A
Recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With th...
Condition
Paroxysmal AF
Enrollment
300 pts
Location
United States
Sponsor
Medtronic Cardiac Ablation Sol
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
NCT06044025 Phase 1
Recruiting
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With B...
Condition
Castration Sensitive Prostate Cancer
Enrollment
34 pts
Location
United States
Sponsor
University of Arkansas
NCT06305091 N/A
Recruiting
DNA Methylation Markers in Veterans Exposed to Open Burn Pits
Condition
Open Burn Pit Exposure
Enrollment
330 pts
Location
United States
Sponsor
Central Arkansas Veterans Heal
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT06567743 Phase 2
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec ...
Condition
High-Risk Non-Muscle-Invasive Bladder Cancer
Enrollment
325 pts
Location
United States
Sponsor
CG Oncology, Inc.
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
NCT06807424 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Bio...
Condition
Arthritis, Psoriatic
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
Page 4 of 4 — 99 trials total